Irena Melnikova1. Show Affiliations » 1. MedaCorp, a division of Leerink Swann, Boston, Massachusetts 02110, USA. irenam@medacorp.com
Abstract
Mesh: See more » Age FactorsAgedAngiogenesis Inhibitors/classificationAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedForecastingHumansMacular Degeneration/economicsMacular Degeneration/etiologyMacular Degeneration/therapyMarketing/trendsMiddle AgedPhototherapyRanibizumab
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedRanibizumab
Year: 2005 PMID: 16178119 DOI: 10.1038/nrd1827
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694